Treatment of Helicobacter pylori infection to reduce gastric cancer incidence: Uncertain benefits of a community based programme in Australia

Journal of Gastroenterology and Hepatology (Australia)

Volumn 13, Issue 11, 1998, Pages 1091-1095

  Forbes, Geoffrey M ^a   Threlfall, Timothy J ^b  

^a ROYAL PERTH HOSPITAL   (Australia)

^b Western Australian Cancer Registry   (Australia)

Author keywords

Cancer prevention; Gastric cancer; Helicobacter pylori; Screening

Indexed keywords

ARTICLE; AUSTRALIA; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; FEMALE; GRAM NEGATIVE INFECTION; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK MANAGEMENT; SCREENING TEST; STOMACH CARCINOMA;

EID: 0031793951     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1998.tb00581.x     Document Type: Article

References (18)

1. NIH Consensus Development Panel for Helicobacter pylori in peptic ulcer disease. Helicobacter pylori in peptic ulcer disease: NIH consensus conference. JAMA 1994; 272: 65-9.
2. Wotherspoon AC, Doglioni C, Diss TC et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575-7.
3. Forbes GM, Glaser ME, Cullen DJE et al. Duodenal ulcer treated with Helicobacter pylori eradication: Seven-year follow-up. Lancet 1994; 343: 258-60.
4. IARC Working Group on the evaluation of carcinogenic risks to humans. Helicobacter pylori. In: Schistosomes, Liver Flukes and Helicobacter pylori: Views and Expert Opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon: IARC, 1994; 177-240.
5. Parsonnet J. Helicobacter pylori and gastric cancer. Gastroenterol. Clin. North Am. 1993; 22: 89-104.
6. Forman D, Newell DG, Fullerton F et al. Association between infection with Helicobacter pylori and risk of gastric cancer: Evidence from a prospective investigation. BMJ 1991; 302: 1302-5.
7. Eurogast Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993; 341: 1359-62.
8. Threlfall TJ, Thompson JR. Cancer incidence and mortality in Western Australia, 1995. Perth: Health Department of Western Australia, 1997.
9. Suvakovic Z, Bramble MG, Jones R, Wilson C, Idle N, Ryott J. Improving the detection rate of early gastric cancer requires more than open access gastroscopy: A five-year study. Gut 1997; 41: 308-13.
10. Hazell HM, Lee A, Berkowicz J, Borody T. The use of serology to diagnose active Campylobacter pylori infection. Med. J. Aust. 1988; 149: 604-9.
11. Parsonnet J, Blaser MJ, Perez-Perez GI, Hargrett-Bean N, Tauxe RV. Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology 1992; 102: 41-6.
12. Forbes GM, Warren JR, Glaser ME, Cullen DJE, Marshall BJ, Collins BJ. Long term follow-up of gastric histology after Helicobacter pylori eradication. J. Gastroenterol. Hepatol. 1996; 11: 670-3.
13. Parsonnet J, Harris RA, Hack HM, Owens DK. Modelling cost effectiveness of Helicobacter pylori screening to prevent gastric cancer: A mandate for clinical trials. Lancet 1996; 348: 150-4.
14. Cullen DJE, Collins BJ, Christiansen KJ et al. When is Helicobacter pylori infection acquired? Gut 1993; 34: 1681-2.
15. Cullen DJE, Christiansen KJ, Epis J, Collins BJ. Familial co-aggregation of Helicobacter pylori infection in the Busselton population. J. Gastroenterol. Hepatol 1995; 10 (Suppl. 2): A37.
16. Forbes GM, Collins BJ, McCullough CA, Commbs GW, Robins PD. Short duration therapy for Helicobacter pylori in Western Australia: The impact of metronidazole resistance. Aust. NZ J. Med. 1998; 28: 13-7.
17. Michetti P. Vaccine against Helicobacter pylori: Fact or fiction. Gut 1997; 41: 728-30.
18. Wain GV. Cervical cancer screening in Australia: Let's keep it in perspective. Med. J. Aust. 1996; 164: 261-2.